Detection of IgA antibody to EBV membrane antigen using Staphylococcus aureus preabsorbed sera is closely associated with nasopharyngeal carcinoma by Pi, G. H. et al.
Journal of Virological Methods, 15 (1987) 33-39 
Elsevier 
33 
JVM 00542 
Detection of IgA antibody to EBV membrane 
antigen using Staphylococcus aweus preabsorbed 
sera is closely associated with nasopharyngeal 
carcinoma 
G.H. Pi’, Y. Zeng’ and H. WolfL 
‘Chinese National Center for Preventive Medicine, Institute of Virology, 100 Ying Xing Jie, Xuan Wu 
Qu, 100052 Beijing, China, and ‘2Max von Pettenkofer-lnstitut, Ludwig-Maximilians-Universitiit, 
Pettenkoferstrasse 9a, 8000 Munich 2, F. R. G. 
(Accepted 16 August 1986) 
The presence of IgA antibody to membrane antigen (MA) of Epstein-Barr virus (EBV) was tested 
in sera from 48 nasopharyngeal carcinoma (NPC) patients. 40 patients with tumors other than NPC and 
46 normal individuals. The sera were preabsorbed with Staphylococcus aureus (SPA) (strain no. 1800) 
prior to their use in the indirect immunofluorescence test. One hundred percent of the NPC patients 
had the IgAiMA antibody with a GMT of 1:141. In patients with tumors other than NPC or normal 
individuals, IgAiMA antibodies were not detectable. The IgAiMA antibodies have been demonstrated 
in 6 NPC patients lacking detectable antibody levels in the indirect immunofluorescence test using non- 
absorbed sera. Our data indicate that preabsorbtion of sera with SPA renders the diagnostic test sig- 
nificantly more sensitive for the detection of the nasopharyngeal carcinoma and can be used for trials 
on the prognosis of patients. 
Nasopharyngeal carcinoma; Epstein-Barr virus; IgAiMA antibody; Staphybcoccus aureus 
Introduction 
Klein et al. (1966) first reported the presence of the membrane antigen (MA) 
of Epstein-Barr virus (EBV) in cell lines established from Burkitts lymphoma (BL) 
by indirect immunofluorescence tests and demonstrated the EBV specificity of MA 
using a direct blocking test (Klein et al., 1969). The antibodies to EBV-MA in sera 
from nasopharyngeal carcinoma (NPC) patients were tested (De Schryver et al., 
1969; Zhu et al., 1986). For the IgA/MA antibody, 58.3% of NPC patients were 
positive with a GMT of 1:7.3 and none of the normal individuals were positive. 
Correspondence IO: H. Wolf, Max von Pettenkofer-Institut, Ludwig-Maximilians-Universitlt, Petten- 
koferstrasse 9a, 8000 Munich 2, F.R.G. 
The detection of IgA/MA antibodies appeared to be specific for NPC, but not as 
sensitive as the detection of IgA/EA which allowed detection rates of up to 70% 
(Zeng et al., 1983a). It is therefore necessary to improve the sensitivity of this test 
for the detection of the IgAiMA antibody. Here we report on a new technique 
and its application for detection of the IgAiMA antibody in NPC patients. 
Materials and Methods 
Seru 
Sera were taken from 48 NPC patients, 40 patients with tumors other than NPC 
and 46 normal individuals. and stored at -20°C. 
Procedure 
The target cells used for detection of the IgAiMA antibody were B95-8 cells, 
activated for 24 h by iz-butyrate (4 mM) and croton oil (500 ngiml). The activated 
cells were washed 3 times with Hank’s solution and adjusted to 2 X lo6 cells/ml. 
110” cells in 50 ~1 were added to each well of 96 well U-shaped hemagglutination 
plates. 
Serum samples were treated prior to titration in the following manner: 25 ml of 
each serum was diluted 1:5 by adding 25 r*_l ~tap~yIoc~ccr~s aweus (SPA) (10% 
suspension of formalin inactivated bacteria; Kessler, 1975) and 7.5 l_~l Hank’s so- 
lution. The mixtures were incubated at 37°C for 1 h and then centrifuged at 
3000 rpm for 20 min. The supernate was considered 1:5 diluted and was further 
diluted from 1:lO to 1:1280 in 2-fold dilution steps. SO ~1 of each dilution of serum 
were added to each well with target cells. The plates were incubated in a humid 
chamber at 37°C for 45 min. After washing 3 times with Hank’s solution, the in- 
cubated cells were smeared on special Teflon-coated slides with clear areas, air dried 
and fixed with cold acetone. 1:lO diluted sheep anti-human IgA antibody conju- 
gated with FITC was added and the slides were kept at 37°C for 45 min. The cell 
smears were again washed 3 times with 0.01 M PBS (pH 7.6). After counter-stain- 
ing with 0.006% Evans blue for 10 min, they were examined under an Olympus 
fluorescence microscope. The cell membrane stained with specific green color was 
considered to be positive. 
Immunoenzymatic test 
The test was done as described by Zeng et al. (1979). 
Results 
Comparison of positive rates of IgA antibodies to VCA, EA and MA in sera from 
NPC patients and control groups 
Sera from 48 NPC patients, from 40 patients with tumors other than NPC and 
from 46 normal individuals were tested for EBV, IgAiEA and IgAiVCA antibod- 
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TABLE 2 
Comparison of the sensitivity of untreated and treated sera with SPA by indirect immunofluorescence 
method. 
Sera from NPC patients &A/MA antibody titers of sera 
Treated by SPA Untreated 
2772 1:20 
2573 1:20 
2519 I:40 
2549 1:x0 
2760 1:80 
2770 I:80 
2771 1:160 
2765 I:160 
2753 I:320 
2747 1:320 
2740 1:64tl 
<5 
<5 
<5 
<5 
15 
<5 
1:lO 
1:20 
1:20 
1:80 
1:Stl 
2794 1:640 1:320 
GMT I:120 1:15 
Normal individuals 
365 1 <5 <5 
3644 <5 <5 
3674 <5 <5 
3652 <S <5 
3649 <5 <5 
3641 <S <5 
3660 <5 <5 
3658 15 <5 
3659 15 <S 
3647 <5 <5 
ies with the immunoenzymatic test and for IgA/MA antibodies with IF using sera 
untreated or preabsorbed with SPA, respectively. The results are given in Table 1. 
Specificity and sensitivity of the modified method 
Previous studies (Zhu et al., 1986) have detected IgAiMA antibodies in only 
58.3% of NPC cases. In order to test whether competing IgG antibodies in the 
remaining 41.7% of sera were responsible for the negative results for IgA/MA an- 
tibodies, sera from 12 NPC patients and 10 normal individuals were tested in par- 
allel using nonabsorbed and SPA-preabsorbed sera, respectively. 
As seen in Table 2, the GMT of the IgA/MA antibody titers were 8 times higher 
in preabsorbed sera. Antibody titers of 1: 160 and higher were found in 50% of the 
preabsorbed sera group but only in one of the 12 nonabsorbed sera. There is no 
positive result in preabsorbed sera from normal individuals. A good correlation 
between antibody titers detected by the modified method and the immunoenzy- 
matic test was obtained (Fig. 1). In most NPC cases, the antibody titers for 
IgAiVCA were higher than for IgAiMA (Fig. 2). 
37 
1260__ 
2 160 __ 
FQ 
E 
4 60-. 0 
10 20 40 60 160 320 640 1260 
IgAlMA Antibody Titers (IF 1 
Fig. 1. Relationship between &A/MA and IgAiEA antibodies in sera from NPC patients as detected 
by the immunoenzymatic test. 
Discussion 
Serological mass surveys were carried out in Zangwu County of the Guangxi 
Autonomous Region in populations with a high risk of developing NPC. The re- 
sults indicate that the detection of IgA antibodies to VCA and EA of EBV is val- 
uable for early diagnosis of NPC (Zeng et al., 1979; Zeng et al., 1980; Zeng et al., 
1983a, b). 58.3% of the NPC patients were found to have IgAiMA antibodies, 
whereas all normal individuals lacked IgA antibodies to this antigen. The situation 
is similar for IgAiEA antibodies (Zeng et al., 1983a), suggesting that detection of 
the IgA/MA antibody could be used as a marker for the diagnosis of NPC. 
However, the detection of EBV IgA/MA antibodies did not seem to be as sen- 
sitive for the diagnosis of NPC as IgANCA antibodies. Here we demonstrated that 
the rate of detection of IgA antibodies to EBV-MA by preabsorbing sera with SPA 
was drastically increased. Forsgren et al. (1966) first reported that SPA can bind 
to the FC sequence of IgG, but it is hardly effective in removing IgA from serum. 
The limited concentration of antigen in the cells used for the fluorescence test 
is apparently competitively blocked by the usually high levels of IgGiMA. Thus, 
the removal of an excess of IgG yielded an enormous increase of sensitivity with- 
out increasing nonspecific reactions. 
This very sensitive test for detection of NPC is easy to perform, reproducible, 
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Fig. 2. Relationship between IgAiMA and IgAiVCA antibodies in sera from NPC patients (IE = im- 
munoenzymatic test. IF = immunofluorescence test). 
and can be used for initial diagnosis and for follow-up studies (therapy control) of 
NPC patients. Because recombinant MA is becoming available (Motz et al., 1986; 
Motz et al., in preparation), this test should soon be available for mass screening. 
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